首页> 美国卫生研究院文献>Applied and Environmental Microbiology >Cloning and Heterologous Production of Hiracin JM79 a Sec-Dependent Bacteriocin Produced by Enterococcus hirae DCH5 in Lactic Acid Bacteria and Pichia pastoris
【2h】

Cloning and Heterologous Production of Hiracin JM79 a Sec-Dependent Bacteriocin Produced by Enterococcus hirae DCH5 in Lactic Acid Bacteria and Pichia pastoris

机译:Hiracin JM79的克隆和异源生产在乳酸菌和毕赤酵母中由平肠肠球菌DCH5产生的Sec依赖性细菌素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hiracin JM79 (HirJM79), a Sec-dependent bacteriocin produced by Enterococcus hirae DCH5, was cloned and produced in Lactococcus lactis, Lactobacillus sakei, Enterococcus faecium, Enterococcus faecalis, and Pichia pastoris. For heterologous production of HirJM79 in lactic acid bacteria (LAB), the HirJM79 structural gene (hirJM79), with or without the HirJM79 immunity gene (hiriJM79), was cloned into the plasmid pMG36c under the control of the constitutive promoter P32 and into the plasmid pNZ8048 under the control of the inducible PNisA promoter. For the production of HirJM79 in P. pastoris, the gene encoding the mature HirJM79 protein was cloned into the pPICZαA expression vector. The recombinant plasmids permitted the production of biologically active HirJM79 in the supernatants of L. lactis IL1403, L. lactis NZ9000, L. sakei Lb790, E. faecalis JH2-2, and P. pastoris X-33, the coproduction of HirJM79 and nisin A in L. lactis DPC5598, and the coproduction of HirJM79 and enterocin P in E. faecium L50/14-2. All recombinant LAB produced larger quantities of HirJM79 than E. hirae DCH5, although the antimicrobial activities of most transformants were lower than that predicted from their production of HirJM79. The synthesis, processing, and secretion of HirJM79 proceed efficiently in recombinant LAB strains and P. pastoris.
机译:Hiracin JM79(HirJM79)是一种由平肠肠球菌DCH5产生的Sec依赖性细菌素,已在乳酸乳球菌,清酒乳杆菌,粪肠球菌,粪肠球菌和巴斯德毕赤酵母中克隆和生产。为了在乳酸菌(LAB)中异源产生HirJM79,在组成型启动子P32的控制下,将带有或不带有HirJM79免疫基因(hiriJM79)的HirJM79结构基因(hirJM79)克隆到质粒pMG36c中,并克隆到质粒中pNZ8048在可诱导的PNisA启动子的控制下。为了在巴斯德毕赤酵母中产生HirJM79,将编码成熟HirJM79蛋白的基因克隆到pPICZαA表达载体中。重组质粒允许在乳酸乳球菌IL1403,乳酸乳球菌NZ9000,清酒乳杆菌Lb790,粪肠球菌JH2-2和巴斯德毕赤酵母X-33的上清液中产生具有生物活性的HirJM79,HirJM79和乳链菌肽的联合生产乳酸乳球菌DPC5598中的A,以及粪肠球菌L50 / 14-2中HirJM79和肠球蛋白P的共同生产。所有重组LAB产生的HirJM79数量均大于 E。 hirae DCH5,尽管大多数转化子的抗菌活性低于其产生的HirJM79的抗菌活性。 HirJM79的合成,加工和分泌在重组LAB菌株和 P中有效进行。 pastoris

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号